CEREVEL THERAPEUTICS HOLDINGS INC. - COMMON STOCK

NetDania - New 12 months Low: CEREVEL THERAPEUTICS HOLDINGS INC. - COMMON STOCK

25 Sep 2023 09:47:11 By NetDania Notify

NetDania - New 12 months Low: CEREVEL THERAPEUTICS HOLDINGS INC. - COMMON STOCK

22 Sep 2023 10:00:08 By NetDania Notify

NetDania - New 12 months Low: CEREVEL THERAPEUTICS HOLDINGS INC. - COMMON STOCK

21 Sep 2023 12:31:40 By NetDania Notify

Cerevel Therapeutics to Present at Morgan Stanley 21st Annual Global Healthcare Conference

29 Aug 2023 06:30:00 By Nasdaq GlobeNewswire

NetDania - New 12 months Low: CEREVEL THERAPEUTICS HOLDINGS INC. - COMMON STOCK

07 Aug 2023 09:47:06 By NetDania Notify

NetDania - New 12 months Low: CEREVEL THERAPEUTICS HOLDINGS INC. - COMMON STOCK

04 Aug 2023 12:31:47 By NetDania Notify

Cerevel Therapeutics Reports Second Quarter 2023 Financial Results and Business Updates

02 Aug 2023 06:30:00 By Nasdaq GlobeNewswire

Cerevel Therapeutics to Report Second Quarter 2023 Financial Results and Business Updates on Wednesday, August 2, 2023

05 Jul 2023 06:30:00 By Nasdaq GlobeNewswire

Cerevel Therapeutics Appoints Paul Burgess as Chief Business Development and Strategic Operations Officer

15 Jun 2023 06:30:00 By Nasdaq GlobeNewswire

Cerevel Therapeutics Appoints Susan Altschuller, Ph.D. as Chief Financial Officer

10 May 2023 06:30:00 By Nasdaq GlobeNewswire

Cerevel Therapeutics Appoints Ron Renaud as President and Chief Executive Officer and Reports First Quarter 2023 Financial Results

03 May 2023 06:30:00 By Nasdaq GlobeNewswire

Cerevel Therapeutics to Present at the BofA Securities 2023 Health Care Conference

26 Apr 2023 06:30:00 By Nasdaq GlobeNewswire

Cerevel Therapeutics to Report First Quarter 2023 Financial Results and Business Updates on Wednesday, May 3, 2023

11 Apr 2023 06:30:00 By Nasdaq GlobeNewswire

Cerevel Therapeutics to Present at the Stifel 2023 CNS Days

21 Mar 2023 06:30:00 By Nasdaq GlobeNewswire

Cerevel Therapeutics to Present at the 43rd Annual Cowen Health Care Conference

02 Mar 2023 06:30:00 By Nasdaq GlobeNewswire

Cerevel Therapeutics Reports Fourth Quarter and Full Year 2022 Financial Results and Business Updates

22 Feb 2023 06:30:00 By Nasdaq GlobeNewswire

Cerevel Therapeutics to Report Fourth Quarter and Full Year 2022 Financial Results and Business Updates on Wednesday, February 22, 2023

01 Feb 2023 06:30:00 By Nasdaq GlobeNewswire

Cerevel Therapeutics to Present at 41st Annual J.P. Morgan Healthcare Conference and Provide Pipeline Update

09 Jan 2023 06:30:00 By Nasdaq GlobeNewswire

Cerevel Therapeutics to Present at the 41st Annual J.P. Morgan Healthcare Conference

04 Jan 2023 06:30:00 By Nasdaq GlobeNewswire

Cerevel Therapeutics Announces Positive Results in Emraclidine Ambulatory Blood Pressure Monitoring Trial

19 Dec 2022 06:30:00 By Nasdaq GlobeNewswire